Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 December 2023

View source ↗

Summary

CVMP adopted a positive opinion for Bravecto (fluralaner) variation to add a new pharmaceutical form (150 mg/ml powder and solvent for suspension for injection)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disease of Dogs

Drugs mentioned

• Bravecto (fluralaner)

Snippet

The Committee adopted by consensus a positive opinion for a variation requiring assessment for Bravecto (fluralaner) concerning the addition of a new pharmaceutical form, 150 mg/ml powder and solvent for suspension for injection, for dogs.